Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Congress

U.S. Senators Introduce ‘Startup Act’ to Reauthorize Regional Innovation Strategies, Implement Commercialization Grants

Westerville, OH, October 1, 2017 — The State Science & Technology Institute (SSTI) reported that U.S. Senators Jerry Moran (R-Kan.) and Mark Warner (D-Va.) along with Senators Roy Blunt (R-Mo.) and Amy Klobuchar (D-Minn.) introduced the Startup Act on September 28.

The legislation would help regions throughout the country address critical gaps between R&D and economic prosperity.

SSTI has worked with the offices on sections of the bill that reauthorize and expand the Regional Innovation Strategies program and would implement a new commercialization grants program.   Continue reading

Senate Panel Strikes Deal to Extend Children’s Health Program (CHIP) Financing for 5 Years

Washington, DC, September 14, 2017 — Robert Pear reported in The New York Times that U.S. Senate Finance Committee Chairman Orrin G. Hatch (R-Utah) and Ranking Member Ron Wyden (D-Oregon) on Tuesday announced that they had reached agreement on a plan to prevent the imminent exhaustion of federal funds for the Children’s Health Insurance Program, commonly known as CHIP.

The current appropriation runs out at the end of this month, and many states will exhaust their allotments of federal money later this year or early next year.

The agreement would provide federal funds for the program for five additional years. Continue reading

NJ Congressional Delegation Requests Rutgers’ Transportation Center Be Designated as Federal Research Center

Washington, DC, September 14, 2017 — Jonathan D. Salant reports in The Star-Ledger that the entire 14-member New Jersey congressional delegation has lined up behind a request to designate Rutgers University’s transportation center as a federal research center.

The designation would bring as much as $14 million in federal funds over five years for the Center for Advanced Infrastructure and Transportation and its partners.

The Rutgers center focuses on bridge safety, highway construction and planning, and transportation research and technology. Continue reading

Congress Rejects President’s Proposals to Cut Health NIH Research Funds

Washington, DC, September 12, 2017 — Robert Pear reports in The New York Times that, back in March, when President Donald J. Trump released the first draft of his budget proposal for the coming fiscal year, he asked lawmakers for deep cuts to one of their favorite institutions, the National Institutes of Health (NIH) — part of a broad reordering of priorities, away from science and social spending, toward defense and border security.

Six months later, Congress has not only rejected the president’s NIH’s proposal, lawmakers from both parties have joined forces to increase spending on biomedical research — and have bragged about it. Continue reading

Senate Appropriators Approve $2 Billion Raise for NIH in 2018

Washington, DC, September 8, 2017 — Lev Facher reports on STAT that the U.S. Senate appropriators on September 7 approved a plan that would increase spending for the National Institutes of Health (NIH) by $2 billion and maintain nearly $300 million in grants for family planning programs that a House committee had sought to eliminate.

The plan would also fund the Substance Abuse and Mental Health Services Administration (SAMHSA) by $387 million more than the amount recommended by President Trump’s budget blueprint.

The bill approved by the Senate Appropriations Committee is perhaps a best-case scenario for boosters of the NIH, family planning advocates, and those fighting the opioid crisis. Continue reading

President to Nominate Pennsylvania Congressman Tom Marino as U.S. Drug Czar

Rep. Tom Marino

Washington, DC, September 5, 2017 — The White House on Friday announced that President Donald Trump will nominate Congressman Tom Marino, a Pennsylvania Republican, to head the the Office of National Drug Control Policy — a position better known as the nation’s drug czar.

In Congress, Marino has worked to expand access to treatment for people struggling with opioid addiction.

The 64-year-old congressman lives outside Williamsport, Pennsylvania, and is a former county prosecutor who served as U.S. attorney in Pennsylvania’s Middle District under President George W. Bush. Continue reading

NIH to Walk Away from $16 Million of NFL Gift for Brain Research

Washington, DC, September 1, 2017The Los Angeles Times reported in July that, five years ago, four months after the suicide of legendary linebacker Junior Seau, the National Football League donated $30 million to the National Institutes of Health (NIH) for brain research.

At the time, the league said its “unrestricted gift” was the largest donation in its history and would help fund a new Sports and Health Research Program to be conducted in collaboration with institutes and centers at the NIH. Continue reading

Congress Faces Deadline to Renew Children’s Health Insurance Program

Washington, DC, August 25, 2017 — Rachel Roubein and Nathaniel Weixel today report in The Hill that Congress is approaching a healthcare deadline with enormous stakes for millions of people — and this time it isn’t about Obamacare.

Federal funding for the Children’s Health Insurance Program (CHIP), which serves 9 million low- and middle-income children, is set to expire at the end of September, setting up a crucial deadline for a Congress already grappling with other high-stakes battle.

The looming deadline for CHIP has been overshadowed by the GOP effort to repeal Obamacare, and lawmakers left town for the summer without addressing the issue. Continue reading

Modern Healthcare Names 100 Most Influential People in Healthcare 2017; Senators Collins, McCain and Murkowski Top List

Senators Susan Collins, John McCain and Lisa Murkowski

Washington, DC, August 24, 2017 — Harris Meyer reports in Modern Healthcare that three Republican senators — Maine’s Susan Collins, Alaska’s Lisa Murkowski and Arizona’s John McCain — decided their party’s bill to repeal the Affordable Care Act would be bad for the states they represent.

Resisting tremendous political pressure, the three voted against Senate Majority Leader Mitch McConnell’s stripped-down ACA repeal bill.

In doing so, they dramatically reshaped the epic political battle over the future of the ACA, which has been bitterly fought over by Republicans and Democrats since it was passed by Democrats on a party-line vote in March 2010. Continue reading

Trump Signs FDA User Fee Agreement into Law; PhRMA and BIO Applaud the Move

Washington, DC, August 21, 2017 — President Donald J. Trump on Friday signed into law a funding package for the Food and Drug Administration (FDA) that also takes steps to lower drug prices.

The FDA Reauthorization Act (FDARA) of 2017 reauthorizes a program in which drug and medical device makers pay the FDA a fee for every new product application.  The agency uses those funds to hire more people and speed up approvals.

The user fee program must be reauthorized every five years. The current program expires at the end of September, and if it hadn’t been signed into law before then, the agency would have had to lay off workers. Continue reading